CXCL12 expression as a prognostic marker in 40 low-grade oligodendrogliomas and oligoastrocytomas

被引：0
|
作者：
Pollo, B. [1 ]
Maderna, E. [1 ]
Calatozzolo, C. [1 ]
Gelati, M. [1 ]
Marras, C. [1 ]
Silvani, A. [1 ]
Croci, D. [1 ]
Boiardi, A. [1 ]
Salmaggi, A. [1 ]
机构：
[1] Ist Nazl Neurol C Besta, Milan, Italy
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [21] CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy
    Kohmo, Satoshi
    Kijima, Takashi
    Mori, Masahide
    Minami, Toshiyuki
    Namba, Yoshinobu
    Yano, Yukihiro
    Yoneda, Tsutomu
    Takeda, Yoshito
    Kitada, Seigo
    Yamaguchi, Toshihiko
    Tachibana, Isao
    Yokota, Soichiro
    TUBERCULOSIS, 2012, 92 (03) : 248 - 252
  • [22] Prognostic significance of CXCL12 protein levels in high-grade serous ovarian carcinoma
    Buisseret, Laurence
    Delisle, Vincent
    Communal, Laudine
    Pommey, Sandra
    Stagg, John
    CANCER RESEARCH, 2016, 76
  • [23] CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival
    Mirisola, Valentina
    Zuccarino, Ambra
    Bachmeier, Beatrice E.
    Sormani, Maria Pia
    Falter, Judith
    Nerlich, Andreas
    Pfeffer, Ulrich
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) : 2579 - 2587
  • [24] CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer
    Stanisavljevic, Luka
    Assmus, Jorg
    Storli, Kristian Eeg
    Leh, Sabine Maria
    Dahl, Olav
    Myklebust, Mette Pernille
    TUMOR BIOLOGY, 2016, 37 (06) : 7441 - 7452
  • [25] Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma
    Masakazu Goto
    Yukiko Shibahara
    Cristina Baciu
    Frances Allison
    Jonathan C. Yeung
    Gail E. Darling
    Mingyao Liu
    Annals of Surgical Oncology, 2021, 28 : 4943 - 4951
  • [26] Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma
    Goto, Masakazu
    Shibahara, Yukiko
    Baciu, Cristina
    Allison, Frances
    Yeung, Jonathan C.
    Darling, Gail E.
    Liu, Mingyao
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 4943 - 4951
  • [27] Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma
    Naidoo, Michael
    Jones, Leanne
    Conboy, Benjamin
    Hamarneh, Wael
    D'Souza, Darwin
    Anthony, Karen
    Machado, Lee R.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma
    Michael Naidoo
    Leanne Jones
    Benjamin Conboy
    Wael Hamarneh
    Darwin D’Souza
    Karen Anthony
    Lee R. Machado
    Scientific Reports, 12
  • [29] Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas
    Gerin, Chloe
    Pallud, Johan
    Deroulers, Christophe
    Varlet, Pascale
    Oppenheim, Catherine
    Roux, Francois-Xavier
    Chretien, Fabrice
    Thomas, Stephen R.
    Grammaticos, Basile
    Badoual, Mathilde
    NEURO-ONCOLOGY, 2013, 15 (10) : 1379 - 1388
  • [30] Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?
    Ruda, Roberta
    Touat, Mehdi
    Soffietti, Riccardo
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (06) : 707 - 715
12345